{"organizations": [], "uuid": "67306ddd40b7436c9ed829ea9f9fa12e2058f7e2", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180130.html", "section_title": "Archive News &amp; Video for Tuesday, 30 Jan 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-strides-shasun-gets-us-fda-approva/brief-strides-shasun-gets-u-s-fda-approval-for-piroxicam-capsules-idUSFWN1PP1IO", "country": "US", "domain_rank": 408, "title": "BRIEF-Strides Shasun Gets U.S. FDA Approval For Piroxicam Capsules", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.998, "site_type": "news", "published": "2018-01-31T12:45:00.000+02:00", "replies_count": 0, "uuid": "67306ddd40b7436c9ed829ea9f9fa12e2058f7e2"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-strides-shasun-gets-us-fda-approva/brief-strides-shasun-gets-u-s-fda-approval-for-piroxicam-capsules-idUSFWN1PP1IO", "ord_in_thread": 0, "title": "BRIEF-Strides Shasun Gets U.S. FDA Approval For Piroxicam Capsules", "locations": [], "entities": {"persons": [], "locations": [{"name": "u.s.", "sentiment": "none"}, {"name": "bangalore", "sentiment": "none"}, {"name": "co", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "shasun ltd", "sentiment": "negative"}, {"name": "fda approval for piroxicam capsules", "sentiment": "negative"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 31 (Reuters) - Strides Shasun Ltd:\n* SAYS CO GETS U.S. FDA APPROVAL FOR PIROXICAM CAPSULES * PRODUCT WILL BE MANUFACTURED AT CO'S ORAL DOSAGE FACILITY AT BANGALORE; WILL BE MARKETED BY STRIDES PHARMA IN U.S. MARKET Source text - bit.ly/2EqTVGU Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html", "http://bit.ly/2EqTVGU"], "published": "2018-01-31T12:45:00.000+02:00", "crawled": "2018-01-31T16:16:56.025+02:00", "highlightTitle": ""}